首页 > 组织芯片 > 前列腺 > MPR483f
tissue microarray-MPR483f
  • 点数:
    48
    例数:
    48
    点样直径(mm):
    2
    厚度(µm):
    5
    行数:
    6
    列数:
    8
    组织阵列类型:
    FFPE
    种属:
    Human
MPR483f
加入收藏

描述: 前列腺癌及前列腺组织组合芯片,附病理分级、TNM、临床分期,48例/48点,替代MPR483e

详情: 前列腺癌及胰腺组织组合微阵列芯片,包含腺癌40例,前列腺组织8例,一例一点

应用: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

备注

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • 说明书列表
  • 重复病例
  • 下载说明书
图表:
Prostate
  • Malignant(I)
  • Malignant(II)
  • Malignant(III)
  • Malignant(IV)
  • Normal(*)
  • _ma
组织芯片
MPR483f
1
2
3
4
5
6
7
8
A
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
B
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
C
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
D
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
E
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
F
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
_ma
MPR483f
  • 年龄:
  • 性别:
  • 器官/解剖部位:
  • 病理诊断:
  • 等级:
  • 分期:
  • 阶段:
  • 组织ID.:
  • 类型:
POS No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Gleason Grade Gleason Score
A1
1 70 M Prostate Adenocarcinoma * T3N0M0 III Malignant 1 3+3
A2
2 73 M Prostate Adenocarcinoma * T3N0M0 III Malignant 1 3+3
A3
3 68 M Prostate Adenocarcinoma (sparse) * T2bN0M0 II Malignant 1 3+3
A4
4 68 M Prostate Adenocarcinoma (sparse) * T1N0M0 I Malignant 2 3+4
A5
5 73 M Prostate Adenocarcinoma * T3N0M0 III Malignant 2 3+4
A6
6 64 M Prostate Adenocarcinoma * T2N0M0 II Malignant 2 3+4
A7
7 75 M Prostate Adenocarcinoma (sparse) * T2N0M0 II Malignant 2 3+4
A8
8 57 M Prostate Adenocarcinoma * T2aN0M0 I Malignant 2 3+4
B1
9 71 M Prostate Adenocarcinoma * T2N0M0 II Malignant 2 3+4
B2
10 66 M Prostate Adenocarcinoma * T2N0M0 II Malignant 2 3+4
B3
11 64 M Prostate Adenocarcinoma * T2N0M0 II Malignant 2 3+4
B4
12 60 M Prostate Adenocarcinoma * T3N1M0 IV Malignant 2 3+4
B5
13 64 M Prostate Adenocarcinoma * T3N0M0 III Malignant 3 4+3
B6
14 73 M Prostate Adenocarcinoma * T2aN0M0 I Malignant 3 4+3
B7
15 75 M Prostate Adenocarcinoma * T3N0M0 III Malignant 3 4+3
B8
16 69 M Prostate Adenocarcinoma * T2N0M0 II Malignant 4 3+5
C1
17 62 M Prostate Adenocarcinoma with necrosis * T2N0M0 II Malignant 4 4+4
C2
18 70 M Prostate Adenocarcinoma * T2N0M0 II Malignant 4 4+4
C3
19 20 M Prostate Adenocarcinoma * T3N0M0 III Malignant 4 4+4
C4
20 66 M Prostate Adenocarcinoma (sparse) * T3N1M1c IV Malignant 4 4+4
C5
21 61 M Prostate Adenocarcinoma * T3N0M0 III Malignant 4 4+4
C6
22 62 M Prostate Adenocarcinoma * T2N0M0 II Malignant 4 4+4
C7
23 69 M Prostate Adenocarcinoma with necrosis * T3N0M0 III Malignant 4 4+4
C8
24 72 M Prostate Adenocarcinoma * T3N0M0 III Malignant 4 4+4
D1
25 71 M Prostate Adenocarcinoma * T2N0M0 II Malignant 4 5+3
D2
26 64 M Prostate Adenocarcinoma * T2N0M0 II Malignant 5 4+5
D3
27 72 M Prostate Adenocarcinoma * T3N0M0 III Malignant 5 4+5
D4
28 74 M Prostate Adenocarcinoma * T2N0M0 II Malignant 5 4+5
D5
29 72 M Prostate Adenocarcinoma * T2N0M0 II Malignant 5 4+5
D6
30 66 M Prostate Adenocarcinoma * T3aN0M0 III Malignant 5 4+5
D7
31 81 M Prostate Adenocarcinoma * T3aN0M0 III Malignant 5 4+5
D8
32 76 M Prostate Adenocarcinoma * T3bN0M0 III Malignant 5 5+4
E1
33 65 M Prostate Adenocarcinoma * T2N0M0 II Malignant 5 5+4
E2
34 70 M Prostate Adenocarcinoma * T2N0M0 II Malignant 5 5+4
E3
35 60 M Prostate Adenocarcinoma * T3aN0M0 III Malignant 5 5+4
E4
36 65 M Prostate Adenocarcinoma * T2N0M0 II Malignant 5 5+4
E5
37 64 M Prostate Adenocarcinoma * T3N0M0 III Malignant 5 5+4
E6
38 80 M Prostate Adenocarcinoma * T3N0M0 III Malignant 5 5+4
E7
39 56 M Prostate Adenocarcinoma * T3N0M0 III Malignant 5 5+4
E8
40 34 M Prostate Adenocarcinoma * T2bN0M0 II Malignant 5 5+5
F1
41 31 M Prostate Prostate tissue * * * Normal * *
F2
42 45 M Prostate Prostate tissue * * * Normal * *
F3
43 30 M Prostate Prostate tissue * * * Normal * *
F4
44 31 M Prostate Prostate tissue * * * Normal * *
F5
45 35 M Prostate Prostate tissue * * * Normal * *
F6
46 50 M Prostate Prostate tissue * * * Normal * *
F7
47 30 M Prostate Prostate tissue (sparse) * * * Normal * *
F8
48 55 M Prostate Prostate tissue * * * Normal * *
_marker_
查找与该芯片存在重复病例的芯片:
如需了解产品规格方面的任何问题,请联系我们
0.177276s